Shopping Cart 0
Cart Subtotal
AED 0

Novasep Holding SAS-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Novasep Holding SAS (Novasep), formerly Groupe Novasep SAS is a pharmaceutical company which offers services in molecule production and purification for life science and chemical industries. The company offers contract manufacturing and development, custom manufacturing, process engineering, scale-up services, supply of equipment and improvement programs. It offers generic APIs and intermediates, bio-pharma equipment, chemicals and polymers, mineral membranes, organic nanofiltration membranes, and chromatography and ion exchange resins. Novasep also carries out purification processes for fermentation and chemical commodities. The company caters to agrochemicals, biopharmaceuticals, fine chemicals, fermentation and chemical commodities; food ingredients, functional ingredients and pharmaceutical sectors. It operates in Europe, the US and Asia. Novasep is headquartered in Lyon, France.

Novasep Holding SAS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10

Groupe Novasep Expands Its Agreement With instrAction 10

Acquisition 11

Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 11

Novasep Holding SAS-Key Competitors 13

Key Employees 14

Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 17

Strategy And Business Planning 17

Feb 23, 2017: Novasep Opens EUR11M New Antibody-drug Conjugate (ADC) Bioconjugation Unit 17

Jun 02, 2016: Novasep opens kilo lab extension at US facility 18

Jan 28, 2016: Novasep adds synthesis and kilo lab extensions to US facility 19

Corporate Communications 20

Mar 07, 2017: Novasep appoints Xavier de Saint Guilhem as Chief Financial Officer 20

Legal and Regulatory 21

Dec 20, 2016: Three Novasep custom manufacturing sites renew FDA approval in 2016 21

Other Significant Developments 22

Feb 13, 2017: Novasep Invests in a EUR27m Viral Vector Production Facility 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Novasep Holding SAS, Pharmaceuticals & Healthcare, Key Facts 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Deals By Therapy Area, 2011 to YTD 2017 8

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10

Groupe Novasep Expands Its Agreement With instrAction 10

Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 11

Novasep Holding SAS, Key Competitors 13

Novasep Holding SAS, Key Employees 14

Novasep Holding SAS, Other Locations 15

Novasep Holding SAS, Subsidiaries 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Novasep Holding SAS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Novasep Holding SAS (Novasep), formerly Groupe Novasep SAS is a pharmaceutical company which offers services in molecule production and purification for life science and chemical industries. The company offers contract manufacturing and development, custom manufacturing, process engineering, scale-up services, supply of equipment and improvement programs. It offers generic APIs and intermediates, bio-pharma equipment, chemicals and polymers, mineral membranes, organic nanofiltration membranes, and chromatography and ion exchange resins. Novasep also carries out purification processes for fermentation and chemical commodities. The company caters to agrochemicals, biopharmaceuticals, fine chemicals, fermentation and chemical commodities; food ingredients, functional ingredients and pharmaceutical sectors. It operates in Europe, the US and Asia. Novasep is headquartered in Lyon, France.

Novasep Holding SAS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10

Groupe Novasep Expands Its Agreement With instrAction 10

Acquisition 11

Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 11

Novasep Holding SAS-Key Competitors 13

Key Employees 14

Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Recent Developments 17

Strategy And Business Planning 17

Feb 23, 2017: Novasep Opens EUR11M New Antibody-drug Conjugate (ADC) Bioconjugation Unit 17

Jun 02, 2016: Novasep opens kilo lab extension at US facility 18

Jan 28, 2016: Novasep adds synthesis and kilo lab extensions to US facility 19

Corporate Communications 20

Mar 07, 2017: Novasep appoints Xavier de Saint Guilhem as Chief Financial Officer 20

Legal and Regulatory 21

Dec 20, 2016: Three Novasep custom manufacturing sites renew FDA approval in 2016 21

Other Significant Developments 22

Feb 13, 2017: Novasep Invests in a EUR27m Viral Vector Production Facility 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

Novasep Holding SAS, Pharmaceuticals & Healthcare, Key Facts 1

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Novasep Holding SAS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Novasep Holding SAS, Deals By Therapy Area, 2011 to YTD 2017 8

Novasep Holding SAS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

Novasep Enters into Partnership with Advanced Biotherapeutics Consulting 10

Groupe Novasep Expands Its Agreement With instrAction 10

Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million 11

Novasep Holding SAS, Key Competitors 13

Novasep Holding SAS, Key Employees 14

Novasep Holding SAS, Other Locations 15

Novasep Holding SAS, Subsidiaries 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Novasep Holding SAS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.